$CDIX

Cardiff Lexington Corp (CDIX): Entry into a Material Definitive Agreement

Cardiff Lexington Corp (CDIX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 cardiff_ex1001.htm COMMON STOCK PURCHASE AGREEMENT, DATED JUNE 5, 2026 Exhibit 10.1 COMMON STOCK PURCHASE AGREEMENT This COMMON STOCK PURCHASE AGREEMENT is made and entered into as of June 5, 2026 (this “ Agreement ”), by and among Leonite Fund I, LP (the “ Investor ”),

Original reporting
Published Jun 11, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$CDIX
Neutral
medium confidence
Mentioned
$CDIX
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CDIXNeutralMed
01

Why it matters

The agreement creates an at-the-company’s-option pathway to issue common stock to the investor in tranches (fixed purchases) during an investment period, subject to conditions and a $0.20 minimum closing sale price for purchase direction.

02

Market read

This is a disclosed equity financing mechanism with a defined maximum commitment and a trading-price gate, which can drive dilution expectations and near-term trading volatility.

03

What to watch

Traders should monitor whether the $0.20 trading-price condition is met and how quickly fixed purchase notices are issued; actual dilution depends on executed settlements, not the maximum commitment.

Relevance 6/10Novelty 8/10Timing: Filed June 11, 2026 (8-K) with agreement dated June 5, 2026

Background

The 8-K reports entry into a Common Stock Purchase Agreement with Leonite Fund I, LP, including registration rights for resale of shares issued under the program.

Company-level read

Ticker impact

$CDIXNeutralMedium confidence
Context

CDIX entered a material definitive common stock purchase agreement allowing the company to sell up to $25M (expandable to $75M) to an investor.

Expected impact

Near-term volatility risk from dilution overhang; price sensitivity likely increases if the stock trades near the $0.20 threshold that governs purchases.

Evidence & confidence

This is a primary SEC 8-K disclosure of a financing structure, but the actual draw size/timing depends on future fixed purchase notices and satisfaction of conditions.

Market effects

Adds another microcap-style equity purchase agreement template, reinforcing dilution/financing risk premia in small-cap growth names.

Primarily US-listed microcap dynamics; limited cross-region spillover expected.

Low—this is company-specific financing mechanics with no stated global macro linkage.

Counterpoint

If the investor’s purchases are executed at favorable prices and the company uses proceeds efficiently, the agreement could reduce funding risk without immediate heavy dilution.

Key entities

  • Cardiff Lexington Corporation

    Nevada corporation issuing common stock under the purchase agreement.

  • Leonite Fund I, LP

    Investor purchasing shares under the fixed purchase mechanism.

  • Registration Rights Agreement

    Provides registration rights for resale of shares issued under the purchase agreement.

Related articles

$CDIXMed

Cardiff Lexington Corporation: Cardiff Lexington Announces Second Quarter 2026 Financial Results

Cardiff Lexington Corporation (OTCQX:CDIX) filed its Form 10-Q for the quarter ended June 30, 2026. The company reported Q2 2026 revenue of $2.16M versus $2.79M in 2025, and a net loss of $2.48M. For six months, revenue fell to $4.38M and net loss was $5.57M. It cited working capital constraints and plans to evaluate debt restructuring and equity infusions.

$LOTTMedAI 8/10

Techlott Signs Definitive Five-Year Platform Agreement with The Gambia’s Exclusive Lottery and Gaming License Holder

Techlott Inc. (OTCQB: LOTT) said it signed a definitive five-year platform and services agreement with the exclusive license holder for lottery and gaming in The Gambia, executed Aug. 6, 2026. Techlott will implement, host, and support the nationwide lottery platform. Compensation includes $7,000 monthly minimums starting Aug. 15, 2026 plus tiered revenue share based on gross platform revenue.

$BMRNMed

BioMarin Targets Faster Deleveraging as Amicus Deal Expands Rare-Disease Growth

BioMarin (NASDAQ:BMRN) said it expects to reach a leverage ratio below 2.5x about a year earlier than planned, targeting mid-next year. It estimates peak revenues of $1.4B for Galafold and $1.2B for Pombiliti/Opfolda in the mid-to-late 2030s, plus synergies about 50% of Amicus legacy costs. BioMarin raised VOXZOGO revenue guidance to at least $1B and reported 14% Q1 growth.

$ABCLMedAI 8/10

AbCellera Unveils $200 Mln Offering Of Shares And Pre-Funded Warrants; Stock Down

AbCellera Biologics (ABCL) said it started an underwritten public offering of $200 million of common shares and pre-funded warrants. The company plans to use net proceeds for continued R&D and clinical progress of ABCL635, plus working capital. It also reported ABCL635 met primary Phase 2 efficacy endpoints for menopausal vasomotor symptoms. ABCL shares fell after the announcement.

$BACMed

Bank of America pledges US$250B for U.S. infrastructure financing

Bank of America said it will deploy $250 billion by July 2027 under its “Critical Infrastructure Finance Initiative” to finance U.S. digital and infrastructure projects. The bank plans primary lending, investments, capital markets services, and advisory across digital infrastructure, energy and power, and core infrastructure. It said the target is measured from Jan 1, 2026 to July 4, 2027.